LONDON — Cyberkinetics Neurotechnology Systems Inc. (Foxborough, Mass.) has demonstrated the use of an implantable microelectrode array that combined with a digital signal processing system forms its so-called "BrainGate" interface, which has been used to allow thought to control a television.
The company also said it has received U.S. Food and Drug Administration approval for limited use of a similar interface called Neuroport. NeuroPort is not intended to enable patients to control a computer with their thoughts. It is intended for temporary monitoring and analysis of electrical activity in the brain, the company said.
Read the article here.
Posts
No comments:
Post a Comment